(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(E,2S)-2,6-dihydroxy-6-methylhept-3-en-2-yl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Details

Top
Internal ID 5dbda35d-2d09-45f6-888c-f8b1fd16dd1a
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(E,2S)-2,6-dihydroxy-6-methylhept-3-en-2-yl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES (Canonical) CC1(C(CCC2(C1C(CC3(C2CC(C4C3(CCC4C(C)(C=CCC(C)(C)O)O)C)O)C)OC5C(C(C(C(O5)CO)O)O)O)C)O)C
SMILES (Isomeric) C[C@]12CC[C@@H](C([C@@H]1[C@H](C[C@@]3([C@@H]2C[C@H]([C@H]4[C@]3(CC[C@@H]4[C@](C)(/C=C/CC(C)(C)O)O)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)(C)C)O
InChI InChI=1S/C36H62O10/c1-31(2,43)12-9-13-36(8,44)19-10-15-34(6)25(19)20(38)16-23-33(5)14-11-24(39)32(3,4)29(33)21(17-35(23,34)7)45-30-28(42)27(41)26(40)22(18-37)46-30/h9,13,19-30,37-44H,10-12,14-18H2,1-8H3/b13-9+/t19-,20+,21-,22+,23+,24-,25-,26+,27-,28+,29-,30+,33+,34+,35+,36-/m0/s1
InChI Key GWXVKQQKVGTQHX-YYGIALSRSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C36H62O10
Molecular Weight 654.90 g/mol
Exact Mass 654.43429817 g/mol
Topological Polar Surface Area (TPSA) 180.00 Ų
XlogP 2.60
Atomic LogP (AlogP) 2.27
H-Bond Acceptor 10
H-Bond Donor 8
Rotatable Bonds 7

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(E,2S)-2,6-dihydroxy-6-methylhept-3-en-2-yl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7368 73.68%
Caco-2 - 0.8335 83.35%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability - 0.7857 78.57%
Subcellular localzation Mitochondria 0.6945 69.45%
OATP2B1 inhibitior - 0.7233 72.33%
OATP1B1 inhibitior + 0.8373 83.73%
OATP1B3 inhibitior + 0.8756 87.56%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6792 67.92%
BSEP inhibitior - 0.6226 62.26%
P-glycoprotein inhibitior + 0.7042 70.42%
P-glycoprotein substrate - 0.6810 68.10%
CYP3A4 substrate + 0.7244 72.44%
CYP2C9 substrate - 0.8007 80.07%
CYP2D6 substrate - 0.8411 84.11%
CYP3A4 inhibition - 0.8665 86.65%
CYP2C9 inhibition - 0.8595 85.95%
CYP2C19 inhibition - 0.8847 88.47%
CYP2D6 inhibition - 0.9547 95.47%
CYP1A2 inhibition - 0.8526 85.26%
CYP2C8 inhibition + 0.6260 62.60%
CYP inhibitory promiscuity - 0.9272 92.72%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.7306 73.06%
Eye corrosion - 0.9915 99.15%
Eye irritation - 0.9195 91.95%
Skin irritation - 0.6144 61.44%
Skin corrosion - 0.9506 95.06%
Ames mutagenesis - 0.8070 80.70%
Human Ether-a-go-go-Related Gene inhibition + 0.7640 76.40%
Micronuclear - 0.8800 88.00%
Hepatotoxicity + 0.5750 57.50%
skin sensitisation - 0.9174 91.74%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity + 0.7556 75.56%
Mitochondrial toxicity + 0.6125 61.25%
Nephrotoxicity - 0.7453 74.53%
Acute Oral Toxicity (c) I 0.5293 52.93%
Estrogen receptor binding + 0.6740 67.40%
Androgen receptor binding + 0.7397 73.97%
Thyroid receptor binding - 0.5056 50.56%
Glucocorticoid receptor binding + 0.5849 58.49%
Aromatase binding + 0.6596 65.96%
PPAR gamma + 0.6690 66.90%
Honey bee toxicity - 0.6205 62.05%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity + 0.5500 55.00%
Fish aquatic toxicity + 0.9231 92.31%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.45% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.44% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 95.45% 97.09%
CHEMBL226 P30542 Adenosine A1 receptor 93.03% 95.93%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.13% 96.09%
CHEMBL218 P21554 Cannabinoid CB1 receptor 90.48% 96.61%
CHEMBL1977 P11473 Vitamin D receptor 89.66% 99.43%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.69% 95.89%
CHEMBL1293249 Q13887 Kruppel-like factor 5 87.07% 86.33%
CHEMBL2996 Q05655 Protein kinase C delta 86.91% 97.79%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.66% 100.00%
CHEMBL5888 Q99558 Mitogen-activated protein kinase kinase kinase 14 85.07% 100.00%
CHEMBL2781 P19634 Sodium/hydrogen exchanger 1 83.97% 90.24%
CHEMBL241 Q14432 Phosphodiesterase 3A 83.42% 92.94%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 83.34% 94.45%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 82.56% 97.33%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 82.08% 96.21%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 81.21% 95.50%
CHEMBL4227 P25090 Lipoxin A4 receptor 80.57% 100.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Panax notoginseng

Cross-Links

Top
PubChem 101693306
LOTUS LTS0142874
wikiData Q27103112